HC
NVO

Hara Capital’s Novo Nordisk NVO Stock Holding History

Hara Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Sell
67,960
-26,714
-28% -$1.15M 1.72% 17
2026
Q1 		$3.59M Buy
94,674
+24,720
+35% +$1.17M 1.79% 13
2025
Q4 		$3.56M Buy
69,954
+23,537
+51% +$1.2M 1.98% 11
2025
Q3 		$2.58M Buy
+46,417
New +$2.72M 1.52% 17

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hara Capital's NVO Position: Q2 2026 in Review

Hara Capital reduced its Novo Nordisk (NVO) stake by 28% in Q2 2026, selling an estimated $1.15M and leaving 67,960 shares worth $3.26M. The position accounts for 1.72% of the portfolio, ranked #17.

Hara Capital first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.59M in Q1 2026. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hara Capital held 67,960 shares of Novo Nordisk worth $3.26M as of Q2 2026.
  • Hara Capital sold 26,714 Novo Nordisk shares in Q2 2026, an estimated $1.15M.
  • Novo Nordisk made up 1.72% of Hara Capital's portfolio in Q2 2026, its #17 holding.
  • Hara Capital first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • Hara Capital's Novo Nordisk position peaked at $3.59M in Q1 2026.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.